Global Blood Therapeutics Inc.

NASDAQ:GBT  
28.94
+1.21 (+4.36%)
Debt Financing / Related

GBT Announces Proposed Offering Of $250.0 Million Of Convertible Senior Notes

Published: 12/14/2021 12:44 GMT
Global Blood Therapeutics Inc. (GBT) - Gbt Announces Proposed Offering of $250.0 Million of Convertible Senior Notes.
Global Blood Therapeutics Inc - Intends to Offer $250.0 Million Aggregate Principal Amount of Its Convertible Senior Notes Due 2028.